In vivo <scp>CRISPR</scp> screens identify <scp>RhoV</scp> as a <scp>pro‐metastasis</scp> factor of <scp>triple‐negative</scp> breast cancer
Ming‐Liang Jin(Shanghai Medical College of Fudan University), Zhi‐Ming Shao(Fudan University)
Cited by 12
Related Papers
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patients
|Nature Communications|2018|183
GCH1 induces immunosuppression through metabolic reprogramming and IDO1 upregulation in triple-negative breast cancer
|Journal for ImmunoTherapy of Cancer|2021|55
Phase II trial of weekly nab-paclitaxel and carboplatin treatment with or without trastuzumab as nonanthracycline neoadjuvant chemotherapy for locally advanced breast cancer
|International Journal of Nanomedicine|2015|21